Recent Finacing
Recent Raise
Nohla Therapeutics develops cryopreserved, off‑the‑shelf HLA‑unmatched hematopoietic stem/progenitor cell therapies from umbilical cord blood using engineered Notch ligand platform; lead candidate in Phase 2 for transplant and chemo‑induced myelosuppression.
